精子数検査市場(技術。顕微鏡法、クロマトグラフィー免疫測定法および比色反応、スマートフォン、その他、エンドユーザー。世界の産業分析、規模、シェア、成長、傾向、予測、2021-2031年Sperm Count Test Market (Technique: Microscopy, Chromatographic Immunoassay and Colorimetric Reaction, Smartphone-based, and Others; and End-user: Hospitals & Clinics, Fertility Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031 精子数検査の市場 - レポートの範囲 TMRの調査レポート「世界の精子数検査市場」は、2021年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会... もっと見る
サマリー精子数検査の市場 - レポートの範囲TMRの調査レポート「世界の精子数検査市場」は、2021年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会も調査しています。当レポートでは、2020年を基準年、2031年を予測年として、2017年から2031年までの世界の精子数検査市場の売上高を掲載しています。また、2021年から2031年までの世界の精子数検査市場の複合年間成長率(CAGR %)を記載しています。 本レポートは、広範な調査を経て作成されました。主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにアナリストがインタビューを行うなど、調査作業の大部分をプライマリリサーチが占めている。二次調査では、精子数検査市場を理解するために、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照しました。 二次調査には、インターネット上の情報源、政府機関の統計データ、ウェブサイト、業界団体なども含まれる。アナリストは、トップダウンアプローチとボトムアップアプローチを組み合わせて、世界の精子数検査市場の様々な属性を調査しました。 本レポートには、調査範囲に含まれる様々なセグメントの成長行動のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、世界の精子数検査市場における競争力学の変化に光を当てています。これらは、既存の市場プレイヤーだけでなく、世界の精子数検査市場への参入に関心のある事業者にとっても貴重なツールとなります。 本レポートでは、世界の精子数検査市場の競争環境について掘り下げています。世界の精子数検査市場で事業を展開する主要企業が特定され、それぞれの企業が様々な属性の観点からプロファイリングされています。会社概要、財務状況、最近の開発、SWOTは、本レポートで紹介された世界の精子数検査市場のプレイヤーの属性です。 精子数検査の世界市場レポートで回答した主要な質問 予測期間中の全地域における精子数検査の売上高/収入はどの程度か? 世界の精子数検査市場におけるビジネスチャンスは? 市場における主なドライバー、阻害要因、機会、脅威は何か? 予測期間中に最も速いCAGRで拡大すると思われる地域市場はどこか? 2031年に世界で最も高い収益を上げると予想されるセグメントは? 予測期間中に最も高いCAGRで拡大すると予測されるセグメントは? 世界市場で事業を展開する各企業の市場ポジションは? 精子数検査市場 - 調査目的と調査アプローチ この調査レポートは、世界の精子数検査市場の概要から始まり、調査の範囲と目的について解説しています。本調査の目的、市場で活動する主要ベンダーと流通業者、製品の承認に関する規制シナリオについて詳しく解説しています。 読みやすさを考慮し、各セクションを細かく分割した章立てのレイアウトで編集しています。また、グラフや表が適切に配置され、網羅的にまとめられています。主要セグメントの実績値および予測値を図式化し、読者に視覚的に訴える。また、過去と予測期間終了時の主要セグメントの市場シェアを比較することができます。 本レポートでは、世界の精子数検査市場をタイプ別、地域別に分析しています。各基準の主要セグメントを詳細に調査し、2031年末時点の各市場シェアを掲載しています。このような貴重な洞察により、市場関係者は世界の精子数検査市場への投資について、十分な情報に基づいたビジネス上の意思決定を行うことができます。 目次1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Sperm Count Test Market 4. Market Overview 4.1. Introduction 4.1.1. Definition 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Sperm Count Test Market Analysis and Forecast, 2017–2031 4.4.1. Market Revenue Projections (US$ Mn) 5. Key Insights 5.1. Overview of Sperm Count Test or Semen Analysis 5.2. Pricing Analysis of Home Sperm Count Test Kits 5.3. Male Infertility Prevalence & Incidence Rate globally with key countries 5.4. Industry Evolution/Developments 5.5. COVID-19 Impact Analysis 6. Global Sperm Count Test Market Analysis and Forecast, by Technique 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Market Value Forecast, by Technique, 2017–2031 6.3.1. Microscopy 6.3.2. Chromatographic Immunoassay and Colorimetric Reaction 6.3.3. Smartphone-based 6.3.4. Others 6.4. Market Attractiveness Analysis, by Technique 7. Global Sperm Count Test Market Analysis and Forecast, by End-user 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Market Value Forecast, by End-user, 2017–2031 7.3.1. Hospitals & Clinics 7.3.2. Fertility Centers 7.3.3. Others 7.4. Market Attractiveness Analysis, by End-user 8. Global Sperm Count Test Market Analysis and Forecast, by Region 8.1. Key Findings 8.2. Market Value Forecast, by Region 8.2.1. North America 8.2.2. Europe 8.2.3. Asia Pacific 8.2.4. Latin America 8.2.5. Middle East & Africa 8.3. Market Attractiveness Analysis, by Country/Region 9. North America Sperm Count Test Market Analysis and Forecast 9.1. Introduction 9.1.1. Key Findings 9.2. Market Value Forecast, by Technique, 2017–2031 9.2.1. Microscopy 9.2.2. Chromatographic Immunoassay and Colorimetric Reaction 9.2.3. Smartphone-based 9.2.4. Others 9.3. Market Value Forecast, by End-user, 2017–2031 9.3.1. Hospitals & Clinics 9.3.2. Fertility Centers 9.3.3. Others 9.4. Market Value Forecast, by Country, 2017–2031 9.4.1. U.S. 9.4.2. Canada 9.5. Market Attractiveness Analysis 9.5.1. By Technique 9.5.2. By End-user 9.5.3. By Country 10. Europe Sperm Count Test Market Analysis and Forecast 10.1. Introduction 10.1.1. Key Findings 10.2. Market Value Forecast, by Technique, 2017–2031 10.2.1. Microscopy 10.2.2. Chromatographic Immunoassay and Colorimetric Reaction 10.2.3. Smartphone-based 10.2.4. Others 10.3. Market Value Forecast, by End-user, 2017–2031 10.3.1. Hospitals & Clinics 10.3.2. Fertility Centers 10.3.3. Others 10.4. Market Value Forecast, by Country/Sub-Region, 2017–2031 10.4.1. Germany 10.4.2. U.K. 10.4.3. France 10.4.4. Spain 10.4.5. Italy 10.4.6. Rest of Europe 10.5. Market Attractiveness Analysis 10.5.1. By Technique 10.5.2. By End-user 10.5.3. By Country/Sub-Region 11. Asia Pacific Sperm Count Test Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.2. Market Value Forecast, by Technique, 2017–2031 11.2.1. Microscopy 11.2.2. Chromatographic Immunoassay and Colorimetric Reaction 11.2.3. Smartphone-based 11.2.4. Others 11.3. Market Value Forecast, by End-user, 2017–2031 11.3.1. Hospitals & Clinics 11.3.2. Fertility Centers 11.3.3. Others 11.4. Market Value Forecast, by Country/Sub-Region, 2017–2031 11.4.1. China 11.4.2. Japan 11.4.3. India 11.4.4. Australia & New Zealand 11.4.5. Rest of Asia Pacific 11.5. Market Attractiveness Analysis 11.5.1. By Technique 11.5.2. By End-user 11.5.3. By Country/Sub-Region 12. Latin America Sperm Count Test Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast, by Technique, 2017–2031 12.2.1. Microscopy 12.2.2. Chromatographic Immunoassay and Colorimetric Reaction 12.2.3. Smartphone-based 12.2.4. Others 12.3. Market Value Forecast, by End-user, 2017–2031 12.3.1. Hospitals & Clinics 12.3.2. Fertility Centers 12.3.3. Others 12.4. Market Value Forecast, by Country/Sub-Region, 2017–2031 12.4.1. Brazil 12.4.2. Mexico 12.4.3. Rest of Latin America 12.5. Market Attractiveness Analysis 12.5.1. By Technique 12.5.2. By End-user 12.5.3. By Country/Sub-Region 13. Middle East & Africa Sperm Count Test Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast, by Technique, 2017–2031 13.2.1. Microscopy 13.2.2. Chromatographic Immunoassay and Colorimetric Reaction 13.2.3. Smartphone-based 13.2.4. Others 13.3. Market Value Forecast, by End-user, 2017–2031 13.3.1. Hospitals & Clinics 13.3.2. Fertility Centers 13.3.3. Others 13.4. Market Value Forecast, by Country/Sub-Region, 2017–2031 13.4.1. GCC Countries 13.4.2. South Africa 13.4.3. Rest of Middle East & Africa 13.5. Market Attractiveness Analysis 13.5.1. By Technique 13.5.2. By End-user 13.5.3. By Country/Sub-Region 14. Competition Landscape 14.1. Market Player - Competition Matrix (by tier and size of companies) 14.2. Company Profiles 14.2.1. SwimCount (MotilityCount ApS) 14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.1.2. Product Portfolio 14.2.1.3. SWOT Analysis 14.2.1.4. Strategic Overview 14.2.2. AB ANALITICA s.r.l. 14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.2.2. Product Portfolio 14.2.2.3. SWOT Analysis 14.2.2.4. Strategic Overview 14.2.3. Diacron International s.r.l. 14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.3.2. Product Portfolio 14.2.3.3. SWOT Analysis 14.2.3.4. Strategic Overview 14.2.4. Artron Laboratories, Inc. 14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.4.2. Product Portfolio 14.2.4.3. SWOT Analysis 14.2.4.4. Strategic Overview 14.2.5. Medical Electronic Systems, LLC 14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.5.2. Product Portfolio 14.2.5.3. SWOT Analysis 14.2.5.4. Strategic Overview 14.2.6. ExSeed Health 14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.6.2. Product Portfolio 14.2.6.3. SWOT Analysis 14.2.6.4. Strategic Overview 14.2.7. Trak Fertility (Standstone Diagnostics) 14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.7.2. Product Portfolio 14.2.7.3. SWOT Analysis 14.2.7.4. Strategic Overview 14.2.8. DNA Diagnostics Center 14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.8.2. Product Portfolio 14.2.8.3. SWOT Analysis 14.2.8.4. Strategic Overview 14.2.9. Microptic SL 14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.9.2. Product Portfolio 14.2.9.3. SWOT Analysis 14.2.9.4. Strategic Overview 14.2.10. Olympus Corporation 14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.10.2. Product Portfolio 14.2.10.3. SWOT Analysis 14.2.10.4. Strategic Overview
SummarySperm Count Test Market – Scope of Report Table of Contents1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Sperm Count Test Market 4. Market Overview 4.1. Introduction 4.1.1. Definition 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Sperm Count Test Market Analysis and Forecast, 2017–2031 4.4.1. Market Revenue Projections (US$ Mn) 5. Key Insights 5.1. Overview of Sperm Count Test or Semen Analysis 5.2. Pricing Analysis of Home Sperm Count Test Kits 5.3. Male Infertility Prevalence & Incidence Rate globally with key countries 5.4. Industry Evolution/Developments 5.5. COVID-19 Impact Analysis 6. Global Sperm Count Test Market Analysis and Forecast, by Technique 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Market Value Forecast, by Technique, 2017–2031 6.3.1. Microscopy 6.3.2. Chromatographic Immunoassay and Colorimetric Reaction 6.3.3. Smartphone-based 6.3.4. Others 6.4. Market Attractiveness Analysis, by Technique 7. Global Sperm Count Test Market Analysis and Forecast, by End-user 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Market Value Forecast, by End-user, 2017–2031 7.3.1. Hospitals & Clinics 7.3.2. Fertility Centers 7.3.3. Others 7.4. Market Attractiveness Analysis, by End-user 8. Global Sperm Count Test Market Analysis and Forecast, by Region 8.1. Key Findings 8.2. Market Value Forecast, by Region 8.2.1. North America 8.2.2. Europe 8.2.3. Asia Pacific 8.2.4. Latin America 8.2.5. Middle East & Africa 8.3. Market Attractiveness Analysis, by Country/Region 9. North America Sperm Count Test Market Analysis and Forecast 9.1. Introduction 9.1.1. Key Findings 9.2. Market Value Forecast, by Technique, 2017–2031 9.2.1. Microscopy 9.2.2. Chromatographic Immunoassay and Colorimetric Reaction 9.2.3. Smartphone-based 9.2.4. Others 9.3. Market Value Forecast, by End-user, 2017–2031 9.3.1. Hospitals & Clinics 9.3.2. Fertility Centers 9.3.3. Others 9.4. Market Value Forecast, by Country, 2017–2031 9.4.1. U.S. 9.4.2. Canada 9.5. Market Attractiveness Analysis 9.5.1. By Technique 9.5.2. By End-user 9.5.3. By Country 10. Europe Sperm Count Test Market Analysis and Forecast 10.1. Introduction 10.1.1. Key Findings 10.2. Market Value Forecast, by Technique, 2017–2031 10.2.1. Microscopy 10.2.2. Chromatographic Immunoassay and Colorimetric Reaction 10.2.3. Smartphone-based 10.2.4. Others 10.3. Market Value Forecast, by End-user, 2017–2031 10.3.1. Hospitals & Clinics 10.3.2. Fertility Centers 10.3.3. Others 10.4. Market Value Forecast, by Country/Sub-Region, 2017–2031 10.4.1. Germany 10.4.2. U.K. 10.4.3. France 10.4.4. Spain 10.4.5. Italy 10.4.6. Rest of Europe 10.5. Market Attractiveness Analysis 10.5.1. By Technique 10.5.2. By End-user 10.5.3. By Country/Sub-Region 11. Asia Pacific Sperm Count Test Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.2. Market Value Forecast, by Technique, 2017–2031 11.2.1. Microscopy 11.2.2. Chromatographic Immunoassay and Colorimetric Reaction 11.2.3. Smartphone-based 11.2.4. Others 11.3. Market Value Forecast, by End-user, 2017–2031 11.3.1. Hospitals & Clinics 11.3.2. Fertility Centers 11.3.3. Others 11.4. Market Value Forecast, by Country/Sub-Region, 2017–2031 11.4.1. China 11.4.2. Japan 11.4.3. India 11.4.4. Australia & New Zealand 11.4.5. Rest of Asia Pacific 11.5. Market Attractiveness Analysis 11.5.1. By Technique 11.5.2. By End-user 11.5.3. By Country/Sub-Region 12. Latin America Sperm Count Test Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast, by Technique, 2017–2031 12.2.1. Microscopy 12.2.2. Chromatographic Immunoassay and Colorimetric Reaction 12.2.3. Smartphone-based 12.2.4. Others 12.3. Market Value Forecast, by End-user, 2017–2031 12.3.1. Hospitals & Clinics 12.3.2. Fertility Centers 12.3.3. Others 12.4. Market Value Forecast, by Country/Sub-Region, 2017–2031 12.4.1. Brazil 12.4.2. Mexico 12.4.3. Rest of Latin America 12.5. Market Attractiveness Analysis 12.5.1. By Technique 12.5.2. By End-user 12.5.3. By Country/Sub-Region 13. Middle East & Africa Sperm Count Test Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast, by Technique, 2017–2031 13.2.1. Microscopy 13.2.2. Chromatographic Immunoassay and Colorimetric Reaction 13.2.3. Smartphone-based 13.2.4. Others 13.3. Market Value Forecast, by End-user, 2017–2031 13.3.1. Hospitals & Clinics 13.3.2. Fertility Centers 13.3.3. Others 13.4. Market Value Forecast, by Country/Sub-Region, 2017–2031 13.4.1. GCC Countries 13.4.2. South Africa 13.4.3. Rest of Middle East & Africa 13.5. Market Attractiveness Analysis 13.5.1. By Technique 13.5.2. By End-user 13.5.3. By Country/Sub-Region 14. Competition Landscape 14.1. Market Player - Competition Matrix (by tier and size of companies) 14.2. Company Profiles 14.2.1. SwimCount (MotilityCount ApS) 14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.1.2. Product Portfolio 14.2.1.3. SWOT Analysis 14.2.1.4. Strategic Overview 14.2.2. AB ANALITICA s.r.l. 14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.2.2. Product Portfolio 14.2.2.3. SWOT Analysis 14.2.2.4. Strategic Overview 14.2.3. Diacron International s.r.l. 14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.3.2. Product Portfolio 14.2.3.3. SWOT Analysis 14.2.3.4. Strategic Overview 14.2.4. Artron Laboratories, Inc. 14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.4.2. Product Portfolio 14.2.4.3. SWOT Analysis 14.2.4.4. Strategic Overview 14.2.5. Medical Electronic Systems, LLC 14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.5.2. Product Portfolio 14.2.5.3. SWOT Analysis 14.2.5.4. Strategic Overview 14.2.6. ExSeed Health 14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.6.2. Product Portfolio 14.2.6.3. SWOT Analysis 14.2.6.4. Strategic Overview 14.2.7. Trak Fertility (Standstone Diagnostics) 14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.7.2. Product Portfolio 14.2.7.3. SWOT Analysis 14.2.7.4. Strategic Overview 14.2.8. DNA Diagnostics Center 14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.8.2. Product Portfolio 14.2.8.3. SWOT Analysis 14.2.8.4. Strategic Overview 14.2.9. Microptic SL 14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.9.2. Product Portfolio 14.2.9.3. SWOT Analysis 14.2.9.4. Strategic Overview 14.2.10. Olympus Corporation 14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.10.2. Product Portfolio 14.2.10.3. SWOT Analysis 14.2.10.4. Strategic Overview
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
Transparency Market Research社のその他分野での最新刊レポート
本レポートと同じKEY WORD(clinics)の最新刊レポート
よくあるご質問Transparency Market Research社はどのような調査会社ですか?トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |